A Phase 1b, Randomized, Placebo-Controlled Study to Assess the Safety and PK of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 02 May 2018
At a glance
- Drugs S 707106 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Shionogi
- 16 Sep 2011 Actual patient number is 34 as reported by ClinicalTrials.gov.
- 13 Sep 2011 Actual end date (November 2010) added as reported by ClinicalTrials.gov.
- 13 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.